2026-10-01 10.45.25 CEST Loihde Oyj - Total number of voting rights and capital Loihde's BLC Turva acquisition completed, directed share issue as part of the purchase price payment ... BLC Turva Oy (FAS).
2026-09-23 14.00.10 CEST Loihde Oyj - Other information disclosed according to the rules of the Exchange The conditions set by Finnish Competition and Consumer Authority for Loihde's acquisition of BLC Turva have been satisfied.
PHO), the Bladder CancerCompany, announces the publication of a new approach to outcome modeling in patients with bladder cancer that undergo a blue light cystoscopy (BLC®) in the peer-reviewed journal Urologic Oncology this week.